CRNT CEO Arazi Doron Ovadia Increases Stake in CRNT

Arazi Doron Ovadia, CEO of CRNT, purchased 133,333 shares on June 11, 2026.

Written by Trueearnings · Published Jun 15, 2026, 7:00 AM EDT · Updated Jun 15, 2026, 11:01 AM EDT

Key Points

Arazi Doron Ovadia, CEO of CRNT, bought 133,333 shares on June 11, 2026, without a planned purchase strategy.
CRNT shares traded at $2.99, with institutional investors like First Wilshire Securities increasing their holdings.
Analysts from Needham and Lake Street have reiterated buy ratings with price targets between $3.0 and $3.5.

Arazi Doron Ovadia, the Chief Executive Officer of CRNT, made a notable purchase of 133,333 shares of the company on June 11, 2026. This transaction was not part of a pre-planned trading strategy, highlighting Ovadia's significant interest in boosting his stake in the company.

Other Institutional Activity in CRNT

In recent activity among institutional investors, First Wilshire Securities Management Inc. increased its holdings by 740,358 shares, bringing its total to 4,854,150 shares, valued at approximately $10.48 million. On the other hand, CSM Advisors, LLC slightly reduced its position by 11,650 shares, ending with 2,272,398 shares worth about $4.91 million. Private Advisor Group, LLC also trimmed its stake by 10,000 shares, leaving it with 1,410,888 shares valued at $3.05 million. WealthTrust Axiom LLC added 43,836 shares, resulting in a total of 944,135 shares valued at $2.04 million. Marshall Wace, LLP established a new position with 707,171 shares, worth about $1.53 million.

CRNT Stock Snapshot

Shares of CRNT traded at $2.99 recently. The stock has been experiencing various levels of institutional interest, which could influence its future performance.

Insider Buying and Selling at CRNT

Aside from Arazi Doron Ovadia's purchase, Efrat Makov, another insider, engaged in several transactions on June 12, 2026. Makov sold 5,000 shares at $2.99 and bought 5,000 shares at $1.99 on the same day. Additionally, Rami Hadar purchased 29,500 shares on May 23, 2026.

Analysts Set New Price Targets

On May 20, 2026, Needham reiterated its buy rating on CRNT with a price target of $3.0. Earlier, on March 31, 2026, Lake Street initiated coverage with a buy rating and a $3.5 target. These ratings suggest a positive outlook from the analyst community.

Bottom Line

CRNT's insider activity, particularly the CEO's purchase, reflects a strong interest in the company's potential. Institutional investors are also adjusting their positions, which could impact the stock's future trajectory. Analysts maintain a positive view, with buy ratings and price targets suggesting confidence in CRNT's prospects. As always, it's important to remember that insider and institutional trades, while informative, are backward-looking and may not reflect current or future strategies.